BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18714303)

  • 1. Development, validation and implementation of immobilized metal affinity for phosphochemicals (IMAP)-based high-throughput screening assays for low-molecular-weight compound libraries.
    Sharlow ER; Leimgruber S; Yellow-Duke A; Barrett R; Wang QJ; Lazo JS
    Nat Protoc; 2008; 3(8):1350-63. PubMed ID: 18714303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
    Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
    Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.
    Horiuchi KY; Ma H
    Methods Mol Biol; 2009; 572():161-76. PubMed ID: 20694691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.
    Sharlow ER; Leimgruber S; Shun TY; Lazo JS
    Assay Drug Dev Technol; 2007 Dec; 5(6):723-35. PubMed ID: 18181689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
    Klumpp M; Boettcher A; Becker D; Meder G; Blank J; Leder L; Forstner M; Ottl J; Mayr LM
    J Biomol Screen; 2006 Sep; 11(6):617-33. PubMed ID: 16760365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dual Readout Assay Based on Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer to Screen for RSK1 Inhibitors.
    Jeong EM; Lee MY; Lee JH; Lee BH; Oh KS
    Biol Pharm Bull; 2016; 39(4):547-55. PubMed ID: 27040627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology.
    Turek-Etienne TC; Kober TP; Stafford JM; Bryant RW
    Assay Drug Dev Technol; 2003 Aug; 1(4):545-53. PubMed ID: 15090251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel scaffolds for IκB kinase beta inhibitor via a high-throughput screening TR-FRET assay.
    Oh KS; Lee S; Choi JK; Lee BH
    Comb Chem High Throughput Screen; 2010 Nov; 13(9):790-7. PubMed ID: 20615197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
    Newman M; Josiah S
    J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel scaffolds for Rho kinase 2 inhibitor through TRFRET-based high throughput screening assay.
    Oh KS; Mun J; Cho JE; Lee S; Yi KY; Lim CJ; Lee JS; Park WJ; Lee BH
    Comb Chem High Throughput Screen; 2013 Jan; 16(1):37-46. PubMed ID: 22934984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using IMAP technology to identify kinase inhibitors: comparison with a substrate depletion approach and analysis of the nature of false positives.
    Singh P; Lillywhite B; Bannaghan C; Broad P
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):319-25. PubMed ID: 16101008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen.
    Tanaka K; Koresawa M; Iida M; Fukasawa K; Stec E; Cassaday J; Chase P; Rickert K; Hodder P; Takagi T; Komatani H
    Assay Drug Dev Technol; 2010 Feb; 8(1):47-62. PubMed ID: 20085455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
    Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
    Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Application of a High-Throughput Fluorescence Polarization Assay to Target Pim Kinases.
    Lee S; Hong VS
    Assay Drug Dev Technol; 2016; 14(1):50-7. PubMed ID: 26824666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases.
    Loomans EE; van Doornmalen AM; Wat JW; Zaman GJ
    Assay Drug Dev Technol; 2003 Jun; 1(3):445-53. PubMed ID: 15090181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.
    Du Y; Nikolovska-Coleska Z; Qui M; Li L; Lewis I; Dingledine R; Stuckey JA; Krajewski K; Roller PP; Wang S; Fu H
    Assay Drug Dev Technol; 2011 Aug; 9(4):382-93. PubMed ID: 21395401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
    Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
    Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
    J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.